RecruitingNCT04088682

Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China


Sponsor

China National Center for Cardiovascular Diseases

Enrollment

200,000 participants

Start Date

Jul 15, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to investigate and evaluate clinical performance and quality measures for adults with acute ST-elevation myocardial infarction (STEMI) in China. Further more, the investigates like to develop quality improvement strategies and relevant tools focusing on treatment and clinical outcome in patients with STEMI. This is a annually survey , through consecutively recruiting all eligible inpatients and collecting relevant medical information, the performance of all participating hospitals. Further, quality improvement strategies including summary of clinical performance and quality measures, clinical pathways and team building will be organized for the purpose of quality improvement. All hospitals will consecutively recruit qualified patients in the same method adopted in baseline period. Then the reperfusion rates and other performance measures will be compared annually.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Patients with STEMI who arrive at the hospital within 48 hours from the symptoms onset.

Exclusion Criteria1

  • None

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALQuality improvement strategies and tools

Quality improvement strategies and tools


Locations(1)

Hongjian Wang

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04088682


Related Trials